{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:08:59Z","timestamp":1763035739700},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1309\/4lte-jhnc-c8rc-fgwl","type":"journal-article","created":{"date-parts":[[2003,1,8]],"date-time":"2003-01-08T10:52:37Z","timestamp":1042023157000},"page":"246-251","source":"Crossref","is-referenced-by-count":29,"title":["Nucleolated Variant of Mantle Cell Lymphoma With Leukemic Manifestations Mimicking Prolymphocytic Leukemia"],"prefix":"10.1093","volume":"117","author":[{"given":"Kit-fai","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-chiu","family":"So","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John K.C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2002,2,1]]},"reference":[{"key":"E00001","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.","journal-title":"J Clin Oncol"},{"key":"E00002","first-page":"115","author":"Campo, E","year":"1999","unstructured":"Campo E, Raffeld M, Jaffe ES. Mantle-cell lymphoma. Semin Hematol. 1999;36:115-127.","journal-title":"Semin Hematol"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/10428199809059246","author":"Ott, G","year":"1998","unstructured":"Ott G, Kalla J, Hanke A, et al. The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features. Leuk Lymphoma. 1998;32:55-63.","journal-title":"Leuk Lymphoma"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2141.1998.00684.x","author":"Cohen, PL","year":"1998","unstructured":"Cohen PL, Kurtin PJ, Donovan KA, et al. Bone marrow and peripheral blood involvement in mantle cell lymphoma. Br J Haematol. 1998;101:302-310.","journal-title":"Br J Haematol"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<850::AID-CNCR22>3.0.CO;2-Z","author":"Wong, KF","year":"1999","unstructured":"Wong KF, Chan JK, So JC, et al. Mantle cell lymphoma in leukemic phase: characterization of its broad cytologic spectrum with emphasis on the importance of distinction from other chronic lymphoproliferative disorders. Cancer. 1999;86:850-857.","journal-title":"Cancer"},{"key":"E00006","first-page":"406","author":"Gerard-Marchant, R","year":"1974","unstructured":"Gerard-Marchant R, Hamlin I, Lennert K, et al. Classification of non-Hodgkin's lymphomas. Lancet. 1974;ii:406-408.","journal-title":"Lancet"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","author":"Banks, PM","year":"1992","unstructured":"Banks PM, Chan J, Cleary ML, et al. Mantle cell lymphoma: a proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol. 1992;16:637-640.","journal-title":"Am J Surg Pathol"},{"key":"E00008","first-page":"494","author":"Neilson, JR","year":"1996","unstructured":"Neilson JR, Fegan CD, Milligan DW. Mantle cell leukaemia [letter]? Br J Haematol. 1996;93:494-495.","journal-title":"Br J Haematol"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/ajcp\/111.4.495","author":"Singleton, TP","year":"1999","unstructured":"Singleton TP, Anderson MM, Ross CW, et al. Leukemic phase of mantle cell lymphoma, blastoid variant. Am J Clin Pathol. 1999;111:495-500.","journal-title":"Am J Clin Pathol"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.leu.2401999","author":"Matutes, E","year":"2001","unstructured":"Matutes E, Wotherspoon A, Brito-Babapulle V, et al. The natural history and clinico-pathological features of the variant form of hairy cell leukemia [letter]. Leukemia. 2001;15:184-193.","journal-title":"Leukemia"},{"key":"E00011","first-page":"567","author":"Cooperative, Group","year":"1989","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al, for the French-American-British (FAB) Cooperative Group. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol. 1989;42:567-584.","journal-title":"J Clin Pathol"},{"key":"E00012","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/gcc.2870050210","volume":"5","author":"Brito-Babapulle","year":"1992","unstructured":"Brito-Babapulle V, Ellis J, Matutes E, et al. Translocation t(11;14)(q13;q32) in chronic lymphoid disorders. Genes Chromosomes Cancer. 1992;5:158-165.","journal-title":"Genes Chromosomes Cancer"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.1995.tb05167.x","volume":"90","author":"Cuneo","year":"1995","unstructured":"Cuneo A, Balboni M, Piva N, et al. Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation. Br J Haematol. 1995;90:409-416.","journal-title":"Br J Haematol"},{"key":"E00014","first-page":"913","volume":"85","author":"De Angeli","year":"2000","unstructured":"De Angeli C, Gandini D, Cuneo A, et al. bcl-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32). Haematologica. 2000;85:913-921.","journal-title":"Haematologica"},{"key":"E00015","first-page":"572","volume":"95","author":"Dascalescu","year":"1996","unstructured":"Dascalescu C, Gressin R, Callanan M, et al. t(11;14)(q13;q32): chronic lymphocytic leukaemia or mantle cell leukaemia [letter]? Br J Haematol. 1996;95:572-573.","journal-title":"Br J Haematol"},{"key":"E00016","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/sj.leu.2401470","volume":"13","author":"Levy","year":"1999","unstructured":"Levy V, Ugo V, Delmer A, et al. Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder. Leukemia. 1999;13:1343-1351.","journal-title":"Leukemia"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/1097-0142(197811)42:5<2360::AID-CNCR2820420537>3.0.CO;2-1","author":"Bearman, RM","year":"1978","unstructured":"Bearman RM, Pangalis GA, Rappaport H. Prolymphocytic leukemia: clinical, histopathological, and cytochemical observations. Cancer. 1978;42:2360-2372.","journal-title":"Cancer"},{"key":"E00018","first-page":"925","volume":"9","author":"Kumar","year":"1996","unstructured":"Kumar S, Green GA, Teruya-Feldstein J, et al. Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocytic lymphoma and mantle cell lymphoma. Mod Pathol. 1996;9:925-929.","journal-title":"Mod Pathol"},{"key":"E00019","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2141.1996.5421085.x","volume":"93","author":"Zoldan","year":"1996","unstructured":"Zoldan MC, Inghirami G, Masuda Y, et al. Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome. Br J Haematol. 1996;93:475-486.","journal-title":"Br J Haematol"},{"key":"E00020","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1200\/JCO.2001.19.5.1414","author":"O'Brien, SM","year":"2001","unstructured":"O'Brien SM, Kantarjian HM, Cortes J, et al. Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. J Clin Oncol. 2001;19:1414-1420.","journal-title":"J Clin Oncol"},{"key":"E00021","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0002-9343(91)80164-H","author":"Kantarjian, HM","year":"1991","unstructured":"Kantarjian HM, Childs C, O'Brien S, et al. Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia. Am J Med. 1991;90:223-228.","journal-title":"Am J Med"},{"key":"E00022","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/blood.V94.7.2217.419k02_2217_2224","volume":"94","author":"Winkler","year":"1999","unstructured":"Winkler U, Jensen M, Manzke O, et al. Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8). Blood. 1999;94:2217-2224.","journal-title":"Blood"},{"key":"E00023","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1200\/JCO.2000.18.2.317","volume":"18","author":"Foran","year":"2000","unstructured":"Foran JM, Rohatiner AZ, Cunningham D, et al. European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma. J Clin Oncol. 2000;18:317-324.","journal-title":"J Clin Oncol"},{"key":"E00024","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/modpathol.3880144","author":"Viswanatha, DS","year":"2000","unstructured":"Viswanatha DS, Foucar K, Berry BR, et al. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma. Mod Pathol. 2000;13:825-833.","journal-title":"Mod Pathol"},{"key":"E00025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1309\/PPK0-TJUK-1UAR-3194","volume":"115","author":"Schlette","year":"2001","unstructured":"Schlette E, Bueso-Ramos C, Giles F, et al. Mature B-cell leukemias with more than 55% prolymphocytes: a heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol. 2001;115:571-581.","journal-title":"Am J Clin Pathol"},{"key":"E00026","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00000478-199801000-00006","author":"Bonato, M","year":"1998","unstructured":"Bonato M, Pittaluga S, Tierens A, et al. Lymph node histology in typical and atypical chronic lymphocytic leukemia. Am J Surg Pathol. 1998;22:49-56.","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/117\/2\/246\/4985000\/ajcpath117-0246.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:09:31Z","timestamp":1583971771000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1309\/4LTE-JHNC-C8RC-FGWL"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2002,2,1]]},"published-print":{"date-parts":[[2002,2]]}},"alternative-id":["10.1309\/4LTE-JHNC-C8RC-FGWL"],"URL":"https:\/\/doi.org\/10.1309\/4lte-jhnc-c8rc-fgwl","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}